BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9234585)

  • 1. The expression of proliferation and quiescence associated antigens in acute myeloid leukemia correlates with survival duration: analysis of 15 refractory cases.
    Visani G; Ottaviani E; Danova M; Mangiarotti R; Tosi P; Tura S
    Haematologica; 1997; 82(3):338-40. PubMed ID: 9234585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
    Drach J; Drach D; Glassl H; Gattringer C; Huber H
    Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen.
    Tafuri A; De Felice L; Petrucci MT; Mascolo MG; Ricciardi MR; Ciliberti C; Martelli MP; Petti MC
    Cytokines Mol Ther; 1995 Dec; 1(4):301-7. PubMed ID: 9384683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
    Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
    Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
    Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
    Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
    Tamura H; Dan K; Tamada K; Nakamura K; Shioi Y; Hyodo H; Wang SD; Dong H; Chen L; Ogata K
    Clin Cancer Res; 2005 Aug; 11(16):5708-17. PubMed ID: 16115907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia.
    Maynadié M; Gerland L; Aho S; Girodon F; Bernier M; Brunet C; Campos L; Daliphard S; Deneys V; Falkenrodt A; Jacob MC; Kühlein E; LeCalvez G; Moskovtchenko P; Philip P; Carli PM; Faure GC; Béné MC;
    Haematologica; 2002 Aug; 87(8):795-803. PubMed ID: 12161354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
    Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F
    Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia.
    Uggla B; Tina E; Nahi H; Paul C; Höglund M; Sirsjö A; Tidefelt U
    Int J Oncol; 2007 Jul; 31(1):153-60. PubMed ID: 17549416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
    Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
    Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes--a comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions.
    Thiele J; Bertsch HP; Kracht LW; Anwander T; Zimmer JD; Kreipe H; Fischer R
    J Pathol; 1994 May; 173(1):5-12. PubMed ID: 7523642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
    Takasaki Y; Robinson WA; Tan EM
    J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
    Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
    Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.